NCT00354445View on ClinicalTrials.gov

A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD

PHASE4UnknownINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

June 30, 2006

Conditions
Age-Related Macular Degeneration (AMD)
Interventions
DRUG

pegaptanib sodium (Macugen)

Trial Locations (1)

79606

RECRUITING

Retina Research Institute of Texas, LLC, Abilene

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Eyetech Pharmaceuticals

INDUSTRY